Mid-Term Clinical Outcome of Patients Undergoing Coronary Artery Bypass Grafting with Valvulotomized Vein Grafts
DOI:
https://doi.org/10.1532/hsf.1960Keywords:
valvulotomized vein grafts, bypass graft patencyAbstract
Background: The lower patency rate of vein grafts (VG) in comparison to arterial grafts may be related to vein valves, which favor turbulences and thrombosis that lead to graft failure. The aim of this study was to determine the outcome of patients with valvulotomized VG after coronary artery bypass grafting (CABG) procedure.
Methods: From 2007 to 2014, 233 patients with a mean age of 67 ± 9 years had CABG or combined CABG and valve procedures. Valvulotomized saphenous VG and arterial grafts were used. Clinical follow-up and outcome were evaluated after 6.3 ± 2 years. The graft patency was rated with multislice computed tomography in 57 patients and coronary angiography in 29 patients 3.1 ± 2 years postoperatively.
Results: Overall, 168 patients had segregated CABG surgery, and 65 patients received additional procedures, with mean 2.7 ± 1 arterial and 1.5 ± 0.7 venous anastomoses. The 30-day-mortality in isolated CABG patients was 2%. Survival at five years was 80%. Major adverse cardiac and cerebrovascular events (MACCE) free rate at five years was 80%. At the last follow up (mean 6.3 years), 94% of the patients were in Canadian Cardiovascular Society (CCS) class 0. The quote of patent valvulotomized VG was 96.1% compared to a patency rate of 96.7% for the arterial grafts in the subgroup undergoing angiography or computed tomography of the heart.
Conclusion: Our data demonstrate good mid-term results of graft patency, and comparable clinical results in patients undergoing CABG with valvulotomized VG. A longer follow-up period and a higher number of bypass graft imaging examinations are necessary to affirm our results.
References
Athanasiou T, Saso S, Rao C, et al. 2011. Radial artery versus saphenous vein conduits for coronary artery bypass surgery: forty years of competition – which conduit offers better patency? A systematic review and meta-analysis. Eur J Cardiothorac Surg 40:208-20.
Buttar SN, Yan TD, Taggart DP, et al. 2017. Long-term and short-term outcomes of using bilateral internal mammary artery grafting versus left internal mammary artery grafting: a meta-analysis. Heart 103:1419-1426.
Calafiore AM, Contini M, Vitolla G, et al. 2000. Bilateral internal thoracic artery grafting: long-term clinical and angiographic results of in situ versus Y grafts. J Thorac Cardiovasc Surg 120:990-6.
Calafiore AM, Teodori G, Bosco G, et al. 1996. Intermittent antegrade warm blood cardioplegia in aortic valve replacement. J Card Surg 11:348-354.
Glineur D, D´hoore W, Price J, et al. 2012. Survival benefit of multiple arterial grafting in a 25-year single institutional experience: the importance of the third arterial graft. Eur J Cardiothorac Surg 42:284-90
Glineur D, Hanet C, D´hoore W, et al. 2009. Causes of non-functioning right internal mammary used in a Y-graft configuration: insight from a 6-month systematic angiographic trial. Eur J Cardiothorac Surg 36:129-136.
Hayward PA, Gordon IR, Hare DL, et al. 2010. Comparable patencies of the radial artery and right internal thoracic artery or saphenous vein beyond 5 years: results from the Radial Artery Patency and Clinical Outcomes trial. J Thorac Cardiovasc Surg 139:60-5.
Joannides R, Haefeli W, Linder L, et al. 1995. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91:1314-9.
Khot UN, Friedman DT, Pettersson G, et al. 2004. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation 109:2086-91.
Lajos TZ, Robicsek F, Thubrikar M, et al. 2007. Improving patency of coronary conduits “valveless” veins and/or arterial grafts. J Card Surg 22:170-7.
Lytle BW, Blackstone EH, Loop FD, et al. 1999. Two internal thoracic artery grafts are better than one. J Thorac Cardiovasc Surg 117:855-72.
Mills NL. 1989. Saphenous vein graft valves: “The bad guys”. Ann Thorac Surg 48:613-4.
Mohr FW, Morice MC, Kappetein AP, et al. 2013. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow up of the randomized, clinical SYNTAX trial. Lancet 381:629-38.
Molina JE. 1989. Nonreversed saphenous vein grafts for coronary artery bypass grafting. Ann Thorac Surg 48:624-7.
Monsefi N, Zierer A, Honarpisheh G, et al. 2016. One-year patency of valvulotomized vein grafts is similar to that of arterial grafts. Thorac Cardiovasc Surg 64:204-10.
Mukherjee D, Cheriyan J, Kourliouros A, et al. 2012. Does the right internal thoracic artery or saphenous vein graft offer superior revascularization of the right coronary artery? Interact Cardiovasc Thorac Surg 15:244-7.
Naik MJ, Abu-Omar Y, Alvi A, et al. 2003. Total arterial revascularisation as a primary strategy for coronary artery bypass grafting. Postgrad Med J 79:43-8.
Risteski PS, Akbulut B, Moritz A, et al. 2006. The radial artery as a conduit for coronary artery bypass grafting: review of current knowledge. Anadolu Kardiyol Derg 6:153-62.
Shah PJ, Bui K, Blackmore S, et al. 2005. Has the in situ right internal thoracic artery been overlooked? An angiographic study of the radial artery, internal thoracic arteries and saphenous vein graft patencies in symptomatic patients. Eur J Cardiothorac Surg 27:870-5.
Taggart DP, D`Amico R, Altman DG. 2001. Effect of arterial revascularisation on survival: a systematic review of studies comparing bilateral and single internal mammary arteries. Lancet 358:870-5.
Thubrikar MJ, Robicsek F, Fowler BL, et al. 1994. Pressure trap created by vein valve closure and its role in graft stenosis. J Thorac Cardiovasc Surg 107:707-16.
Wimmer-Greinecker G, Yosseef-Hakimi M, Rinne T, et al. 1999. Effect of internal thoracic artery preparation on blood loss, lung function, and pain. Ann Thorac Surg 6:153-162.
